PHARM — Pharming NV Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Pharming NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	199	206	245	297	376
Cost of Revenue
Gross Profit	178	188	220	262	331
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	185	187	251	306	350
Operating Profit	13.6	18.2	-5.39	-8.62	25.8
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	23.1	15	-12	-8.49	12.8
Provision for Income Taxes
Net Income After Taxes	16	13.7	-10.5	-11.8	2.54
Minority Interest
Net Income Before Extraordinary Items
Net Income	16	13.7	-10.5	-11.8	2.85
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	16	13.7	-10.5	-11.8	2.85
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.038	0.009	-0.032	-0.013	0.014